Business · 10/04/2018Updated: 10/17/2026 · 1 min read
FDA Approves Several Products Redeeming Rare Pediatric Disease Priority Review Vouchers
Summary
The FDA has announced the approval of multiple products that utilize priority review vouchers, which are awarded to sponsors of rare pediatric disease product applications that meet specific criteria, as mandated by the FD&C Act and FDASIA.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →